Unified Network for Integrated Fluid Collection at Yale

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT07689864
Status
Recruiting
Apply to this trial

Conditions

  • Cancer
  • Molecular Residual Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

UNIFY is a Yale-wide liquid biopsy master repository that prospectively collects Streck-tube blood, dried blood spots (and optional archival tissue) from Yale Cancer Center patients across all tumor types for current and future research.

Key Dates

First listed
Jul 8, 2026
Start date
Aug 25, 2026
Status verified
Aug 2026
Primary completion
Aug 31, 2031
Completion
Aug 31, 2031

Study Design

Enrollment
2,500 participants (estimated)

Arms

  • Arm: UNIFY
    Patients enrolled in UNIFY only, with biological samples and limited clinical data collected as stipulated by this protocol
  • Arm: UNIFY plus
    UNIFY plus a co-enrolled primary research study: Patients concurrently enrolled in a separate IRB-approved under UNIFY, limited clinical data will be collected for this cohort under the primary research study that requires blood sampling and optional or mandatory tumor tissue collection for research purposes.

Primary Outcome Measure

Collection and annotation of biospecimens [ Time Frame: Through study completion, up to 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Smilow Cancer HospitalNew HavenConnecticut06519-

Find similar trials in New Haven, CT

By research site
Smilow Cancer Hospital· New Haven, CT

Related Studies